Gerresheimer earned EcoVadis Gold: Gerresheimer stock trades 1.42 percent lower
Published on 10/27/2026 at 09:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSOperating recovery and upcoming dates
- Gerresheimer received an EcoVadis Gold award on October 13, 2026.
- Second-quarter adjusted EBITDA reached EUR 102 million on September 30, 2026.
- Gerresheimer stock trades at EUR 32.53 at 9:41 a.m. CET at Lang & Schwarz on October 27, 2026, 1.42 percent below the Xetra close of October 26, 2026.
Gerresheimer (ISIN DE000A0LD6E6) was trading at EUR 32.53 at Lang & Schwarz on October 27, 2026, at 9:41 a.m. CET, down 1.42 percent versus the Xetra close of October 26, 2026, at EUR 33.00. The company earned an EcoVadis Gold award on October 13, 2026, according to Gerresheimer.
EcoVadis rating adds a signal
The October 13 award is the latest corporate item listed by Gerresheimer. It followed the October 1 completion of the Centor sale, a portfolio step that had been prepared alongside the second-quarter recovery.
What does the margin recovery mean?
The operating picture improved sequentially, but the year-on-year comparison stayed challenging. In preliminary second-quarter results dated September 30, 2026, revenue reached EUR 578 million, up EUR 55 million from the first quarter, while adjusted EBITDA rose EUR 35 million to EUR 102 million, according to Gerresheimer. The adjusted EBITDA margin reached 17.6 percent in the quarter, compared with 15.3 percent for the first half of 2026.
Three company milestones
Gerresheimer's recent sequence combines portfolio action and operational recovery. On July 29, 2026, it announced the sale of Centor and the global Primary Packaging Plastics business to Apax Funds. On September 30, 2026, second-quarter revenue stood at EUR 578 million and adjusted EBITDA at EUR 102 million. On October 13, 2026, the company listed the EcoVadis Gold award, according to its investor-relations page.
Upcoming dates matter
The financial calendar lists the half-year financial report for November 2026 and the Berenberg European Conference for December 2, 2026, according to Gerresheimer. The same calendar places the third-quarter statement in December 2026. Those dates give investors the next checkpoints for the recovery and the portfolio changes.
Stock stays below the October close
The current euro quote is below the previous Xetra session's EUR 33.00 close, while the latest company figures show a sharper sequential improvement in adjusted EBITDA than in revenue. That combination leaves the next report responsible for testing whether the second-half recovery can broaden beyond the strongest segments. Gerresheimer was trading at EUR 32.53 at Lang & Schwarz on October 27, 2026, at 9:41 a.m. CET, 1.42 percent below the Xetra close of October 26, 2026, at EUR 33.00. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.
Gerresheimer stock key data
- Company: Gerresheimer AG
- ISIN: DE000A0LD6E6
- WKN: A0LD6E
- Ticker: GXI
- Primary exchange: Xetra
- Price Lang & Schwarz as of October 27, 2026, 9:41 a.m. CET: EUR 32.53
- Change versus Xetra close: minus 1.42 percent
- Xetra close October 26, 2026: EUR 33.00
- Market capitalization: EUR 1.1 billion as of October 27, 2026
- 52-week range: EUR 14.83-EUR 34.20 as of October 27, 2026
- Sector / Industry: Materials / Medical devices and diagnostics
Market context: Market report DAX.
